Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence. Danazol is also effective in some persons with PMF and anemia. Responses to these drugs are typically incomplete and not...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Cancer J
Hoofdauteurs: Luo, Xueping, Xu, Zefeng, Li, Bing, Qin, Tiejun, Zhang, Peihong, Zhang, Hongli, Fang, Liwei, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Zhang, Yue, Huang, Gang, Peter Gale, Robert, Xiao, Zhijian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802625/
https://ncbi.nlm.nih.gov/pubmed/29335406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0029-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items